155 related articles for article (PubMed ID: 29564913)
81. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
Li YB; Lin LZ; Guan JS; Chen CM; Zuo Q; Lin BQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1076-1081. PubMed ID: 30645846
[TBL] [Abstract][Full Text] [Related]
82. miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis.
Solé C; Cortés-Hernández J; Felip ML; Vidal M; Ordi-Ros J
Nephrol Dial Transplant; 2015 Sep; 30(9):1488-96. PubMed ID: 26040904
[TBL] [Abstract][Full Text] [Related]
83. [A review on muscle-specific microRNAs as the biomarker for Duchenne muscular dystrophy].
Meng Q; Lan D
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Nov; 21(11):1148-1152. PubMed ID: 31753100
[TBL] [Abstract][Full Text] [Related]
84. Noncoding RNAs and Duchenne muscular dystrophy.
Perry MM; Muntoni F
Epigenomics; 2016 Nov; 8(11):1527-1537. PubMed ID: 27603567
[TBL] [Abstract][Full Text] [Related]
85. Ocular toxoplasmosis associated with up-regulation of miR-155-5p/miR-29c-3p and down-regulation of miR-21-5p/miR-125b-5p.
Meira-Strejevitch CS; Pereira IS; Hippólito DDC; Maia MM; Cruz AB; Gava R; Brandão de Mattos CC; Frederico FB; Siqueira RC; Mattos LC; Pereira-Chioccola VL
Cytokine; 2020 Mar; 127():154990. PubMed ID: 31945658
[TBL] [Abstract][Full Text] [Related]
86. Forms of diagnostic material as sources of miRNA biomarkers in hepatocellular carcinoma: a preliminary study.
Świtlik WZ; Bielecka-Kowalska A; Karbownik MS; Kordek R; Jabłkowski M; Szemraj J
Biomark Med; 2019 May; 13(7):523-534. PubMed ID: 30854869
[No Abstract] [Full Text] [Related]
87. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
Thongsing A; Likasitwattanakul S; Sanmaneechai O
Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
[TBL] [Abstract][Full Text] [Related]
88. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
89. Renal function in children and adolescents with Duchenne muscular dystrophy.
Braat E; Hoste L; De Waele L; Gheysens O; Vermeersch P; Goffin K; Pottel H; Goemans N; Levtchenko E
Neuromuscul Disord; 2015 May; 25(5):381-7. PubMed ID: 25683700
[TBL] [Abstract][Full Text] [Related]
90. Abnormal regulation of microRNAs and related genes in pediatric β-thalassemia.
Wang H; Chen M; Xu S; Pan Y; Zhang Y; Huang H; Xu L
J Clin Lab Anal; 2021 Sep; 35(9):e23945. PubMed ID: 34398996
[TBL] [Abstract][Full Text] [Related]
91. Comparison of two corticosteroid regimens on brain volumetrics in patients with Duchenne muscular dystrophy.
Geuens S; Van Dessel J; Govaarts R; Ikelaar NA; Meijer OC; Kan HE; Niks EH; Goemans N; Lemiere J; Doorenweerd N; De Waele L
Ann Clin Transl Neurol; 2023 Dec; 10(12):2324-2333. PubMed ID: 37822297
[TBL] [Abstract][Full Text] [Related]
92. Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients.
Oonk S; Spitali P; Hiller M; Switzar L; Dalebout H; Calissano M; Lochmüller H; Aartsma-Rus A; 't Hoen PA; van der Burgt YE
Proteomics Clin Appl; 2016 Mar; 10(3):290-9. PubMed ID: 26680509
[TBL] [Abstract][Full Text] [Related]
93. Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients.
Li X; Li Y; Zhao L; Zhang D; Yao X; Zhang H; Wang YC; Wang XY; Xia H; Yan J; Ying H
Mol Ther Nucleic Acids; 2014 Jul; 3(7):e177. PubMed ID: 25050825
[TBL] [Abstract][Full Text] [Related]
94. Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy.
Passarelli C; Selvatici R; Carrieri A; Di Raimo FR; Falzarano MS; Fortunato F; Rossi R; Straub V; Bushby K; Reza M; Zharaieva I; D'Amico A; Bertini E; Merlini L; Sabatelli P; Borgiani P; Novelli G; Messina S; Pane M; Mercuri E; Claustres M; Tuffery-Giraud S; Aartsma-Rus A; Spitali P; T'Hoen PAC; Lochmüller H; Strandberg K; Al-Khalili C; Kotelnikova E; Lebowitz M; Schwartz E; Muntoni F; Scapoli C; Ferlini A
Front Genet; 2020; 11():605. PubMed ID: 32719714
[TBL] [Abstract][Full Text] [Related]
95. A longitudinal study of creatine kinase and creatinine levels in Duchenne muscular dystrophy.
Zygmunt AM; Wong BL; Horn PS; Lambert J; Bange JE; Rybalsky I; Chouteau W; Tian C
Muscle Nerve; 2023 Feb; 67(2):138-145. PubMed ID: 36444146
[TBL] [Abstract][Full Text] [Related]
96. Cytomorphometric Evaluation of Oral Mucosa of Patients with Duchenne Muscular Dystrophy.
Macedo DS; Jacomo TS; Moraes B; Ortega KL; Braz-Silva PH; Zonta MA; Pallos D; Martins F
Head Neck Pathol; 2022 Sep; 16(3):703-706. PubMed ID: 35064903
[TBL] [Abstract][Full Text] [Related]
97. Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life?
Sienko S; Buckon C; Fowler E; Bagley A; Staudt L; Sison-Williamson M; Zebracki K; McDonald CM; Sussman M
PLoS Curr; 2016 Jun; 8():. PubMed ID: 27525172
[TBL] [Abstract][Full Text] [Related]
98. Identification of Auxiliary Biomarkers and Description of the Immune Microenvironmental Characteristics in Duchenne Muscular Dystrophy by Bioinformatical Analysis and Experiment.
Han X; Han J; Wang N; Ji G; Guo R; Li J; Wu H; Ma S; Fang P; Song X
Front Neurosci; 2022; 16():891670. PubMed ID: 35720684
[TBL] [Abstract][Full Text] [Related]
99. Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study.
Labisa P; Andreozzi V; Mota M; Monteiro S; Alves R; Almeida J; Vandewalle B; Felix J; Buesch K; Canhão H; Beitia Ortiz de Zarate I
Pharmacoecon Open; 2022 Mar; 6(2):211-218. PubMed ID: 34604937
[TBL] [Abstract][Full Text] [Related]
100. Deciphering the Molecular Mechanism of Incurable Muscle Disease by a Novel Method for the Interpretation of miRNA Dysregulation.
Israeli D; Vu Hong A; Corre G; Miagoux Q; Richard I
Noncoding RNA; 2022 Jun; 8(4):. PubMed ID: 35893231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
